COVID-19 antibodies persist, reduce reinfection risk for up to six months: Study – Sify News

Michigan [US], September 15 (ANI): A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.


See this full article at Sify News

Other news: